Connect with us

Cannabis

More than £38,000 and large haul of cannabis found in Gateshead home

Avatar

Published

on

Three people have been arrested after large quantities of cash and drugs were seized at a home in Gateshead.

On Monday, officers raided a house on Heworth Burn Crescent, Felling, following intelligence that drugs were inside the property.

During the raid, officers seized several kilos of vacuum packed cannabis and over £38,000 worth of cash.

Police then arrested three males aged 14, 37 and 47 on suspicion of drug offences.

Detective Sergeant Chris Johnson, of Northumbria Police, said: “This has been a fantastic result by one of our local police teams who worked hard to see a positive result.

“Not only have three suspects been arrested but we have also successfully taken a large quantity of drugs off the street and stopped thousands of pounds being used for further suspected criminality.

“This investigation and other types of robust disruption work will continue. Drug offences are dangerous and damage communities and we will not stand for it.




“We urge anyone with concerns or information about drugs to contact us so we can continue ridding our streets of supply and individuals who think they can prey on and profit from the vulnerable.”

The three males arrested have since been released under investigation while enquiries continue.

Anyone who is concerned about drug use or supply in their community can contact police on 101 or via the Northumbria Police website.

Alternatively you can report anonymously via the independent charity Crimestoppers on 0800 555 111.

Source: https://mmpconnect.com/more-than-38000-and-large-haul-of-cannabis-found-in-gateshead-home/

Cannabis

Extra Crunch roundup: Antitrust jitters, SPAC odyssey, white-hot IPOs, more

Avatar

Published

on

Some time ago, I gave up on the idea of finding a thread that connects each story in the weekly Extra Crunch roundup; there are no unified theories of technology news.

The stories that left the deepest impression were related to two news pegs that dominated the week — Visa and Plaid calling off their $5.3 billion acquisition agreement, and sizzling-hot IPOs for Affirm and Poshmark.

Watching Plaid and Visa sing “Let’s Call The Whole Thing Off” in harmony after the U.S. Department of Justice filed a lawsuit to block their deal wasn’t shocking. But I was surprised to find myself editing an interview Alex Wilhelm conducted with Plaid CEO Zach Perret the next day in which the executive said growing the company on its own is “once again” the correct strategy.


Full Extra Crunch articles are only available to members
Use discount code ECFriday to save 20% off a one- or two-year subscription


In an analysis for Extra Crunch, Managing Editor Danny Crichton suggested that federal regulators’ new interest in antitrust enforcement will affect valuations going forward. For example, Procter & Gamble and women’s beauty D2C brand Billie also called off their planned merger last week after the Federal Trade Commission raised objections in December.

Given the FTC’s moves last year to prevent Billie and Harry’s from being acquired, “it seems clear that U.S. antitrust authorities want broad competition for consumers in household goods,” Danny concluded, and I suspect that applies to Plaid as well.

In December, C3.ai, Doordash and Airbnb burst into the public markets to much acclaim. This week, used clothing marketplace Poshmark saw a 140% pop in its first day of trading and consumer-financing company Affirm “priced its IPO above its raised range at $49 per share,” reported Alex.

In a post titled “A theory about the current IPO market”, he identified eight key ingredients for brewing a debut with a big first-day pop, which includes “exist in a climate of near-zero interest rates” and “keep companies private longer.” Truly, words to live by!

Come back next week for more coverage of the public markets in The Exchange, an interview with Bustle CEO Bryan Goldberg where he shares his plans for taking the company public, a comprehensive post that will unpack the regulatory hurdles facing D2C consumer brands, and much more.

If you live in the U.S., enjoy your MLK Day holiday weekend, and wherever you are: Thanks very much for reading Extra Crunch.

Walter Thompson
Senior Editor, TechCrunch
@yourprotagonist

Rapid growth in 2020 reveals OKR software market’s untapped potential

After spending much of the week covering 2021’s frothy IPO market, Alex Wilhelm devoted this morning’s column to studying the OKR-focused software sector.

Measuring objectives and key results are core to every enterprise, perhaps more so these days since knowledge workers began working remotely in greater numbers last year.

A sign of the times: This week, enterprise orchestration SaaS platform Gtmhub announced that it raised a $30 million Series B.

To get a sense of how large the TAM is for OKR, Alex reached out to several companies and asked them to share new and historical growth metrics:

  • Gthmhub
  • Perdoo
  • WorkBoard
  • Ally.io
  • Koan
  • WeekDone

“Some OKR-focused startups didn’t get back to us, and some leaders wanted to share the best stuff off the record, which we grant at times for candor amongst startup executives,” he wrote.

5 consumer hardware VCs share their 2021 investment strategies

For our latest investor survey, Matt Burns interviewed five VCs who actively fund consumer electronics startups:

  • Hans Tung, managing partner, GGV Capital
  • Dayna Grayson, co-founder and general partner, Construct Capital
  • Cyril Ebersweiler, general partner, SOSV
  • Bilal Zuberi, partner, Lux Capital
  • Rob Coneybeer, managing director, Shasta Ventures

“Consumer hardware has always been a tough market to crack, but the COVID-19 crisis made it even harder,” says Matt, noting that the pandemic fueled wide interest in fitness startups like Mirror, Peloton and Tonal.

Bonus: Many VCs listed the founders, investors and companies that are taking the lead in consumer hardware innovation.

A theory about the current IPO market

Image Credits: Getty Images/Andriy Onufriyenko

If you’re looking for insight into “why everything feels so damn silly this year” in the public markets, a post Alex wrote Thursday afternoon might offer some perspective.

As someone who pays close attention to late-stage venture markets, he’s identified eight factors that are pushing debuts for unicorns like Affirm and Poshmark into the stratosphere.

TL;DR? “Lots of demand, little supply, boom goes the price.”

Poshmark prices IPO above range as public markets continue to YOLO startups

Clothing resale marketplace Poshmark closed up more than 140% on its first trading day yesterday.

In Thursday’s edition of The Exchange, Alex noted that Poshmark boosted its valuation by selling 6.6 million shares at its IPO price, scooping up $277.2 million in the process.

Poshmark’s surge in trading is good news for its employees and stockholders, but it reflects poorly on “the venture-focused money people who we suppose know what they are talking about when it comes to equity in private companies,” he says.

Will startup valuations change given rising antitrust concerns?

Image Credits: monsitj/Getty Images

This week, Visa announced it would drop its planned acquisition of Plaid after the U.S. Department of Justice filed suit to block it last fall.

Last week, Procter & Gamble called off its purchase of Billie, a women’s beauty products startup — in December, the U.S. Federal Trade Commission sued to block that deal, too.

Once upon a time, the U.S. government took an arm’s-length approach to enforcing antitrust laws, but the tide has turned, says Managing Editor Danny Crichton.

Going forward, “antitrust won’t kill acquisitions in general, but it could prevent the buyers with the highest reserve prices from entering the fray.”

Dear Sophie: What’s the new minimum salary required for H-1B visa applicants?

Image Credits: Sophie Alcorn

Dear Sophie:

I’m a grad student currently working on F-1 STEM OPT. The company I work for has indicated it will sponsor me for an H-1B visa this year.

I hear the random H-1B lottery will be replaced with a new system that selects H-1B candidates based on their salaries.

How will this new process work?

— Positive in Palo Alto

Venture capitalists react to Visa-Plaid deal meltdown

Image Credits: Ana Maria Serrano/Getty Images

After news broke that Visa’s $5.3 billion purchase of API startup Plaid fell apart, Alex Wilhelm and Ron Miller interviewed several investors to get their reactions:

  • Anshu Sharma, co-founder and CEO, SkyflowAPI
  • Amy Cheetham, principal, Costanoa Ventures
  • Sheel Mohnot, co-founder, Better Tomorrow Ventures
  • Lucas Timberlake, partner, Fintech Ventures
  • Nico Berardi, founder and general partner, ANIMO Ventures
  • Allen Miller, VC, Oak HC/FT
  • Sri Muppidi, VC, Sierra Ventures
  • Christian Lassonde, VC, Impression Ventures

Plaid CEO touts new ‘clarity’ after failed Visa acquisition

Image Credits: George Frey/Bloomberg/Getty Images

Alex Wilhelm interviewed Plaid CEO Zach Perret after the Visa acquisition was called off to learn more about his mindset and the company’s short-term plans.

Perret, who noted that the last few years have been a “roller coaster,” said the Visa deal was the right decision at the time, but going it alone is “once again” Plaid’s best way forward.

2021: A SPAC odyssey

In Tuesday’s edition of The Exchange, Alex Wilhelm took a closer look at blank-check offerings for digital asset marketplace Bakkt and personal finance platform SoFi.

To create a detailed analysis of the investor presentations for both offerings, he tried to answer two questions:

  1. Are special purpose acquisition companies a path to public markets for “potentially promising companies that lacked obvious, near-term growth stories?”
  2. Given the number of unicorns and the limited number of companies that can IPO at any given time, “maybe SPACS would help close the liquidity gap?”

Flexible VC: A new model for startups targeting profitability

12 ‘flexible VCs’ who operate where equity meets revenue share

Image Credits: MirageC/Getty Images

Growth-stage startups in search of funding have a new option: “flexible VC” investors.

An amalgam of revenue-based investment and traditional VC, investors who fall into this category let entrepreneurs “access immediate risk capital while preserving exit, growth trajectory and ownership optionality.”

In a comprehensive explainer, fund managers David Teten and Jamie Finney present different investment structures so founders can get a clear sense of how flexible VC compares to other venture capital models. In a follow-up post, they share a list of a dozen active investors who offer funding via these nontraditional routes.

These 5 VCs have high hopes for cannabis in 2021

Image Credits: Anton Petrus (opens in a new window)/Getty Images

For some consumers, “cannabis has always been essential,” writes Matt Burns, but once local governments allowed dispensaries to remain open during the pandemic, it signaled a shift in the regulatory environment and investors took notice.

Matt asked five VCs about where they think the industry is heading in 2021 and what advice they’re offering their portfolio companies:

Source: https://techcrunch.com/2021/01/15/extra-crunch-roundup-antitrust-jitters-spac-odyssey-white-hot-ipos-more/

Continue Reading

Cannabis

Subversive Capital Acquisition Corp. Closes The Largest Cannabis SPAC In History

Avatar

Published

on

  • The Parent Company, Formerly Subversive Capital Acquisition Corp., has Completed its Qualifying Transaction and is Now the Largest Vertically Integrated Cannabis Operation in California
  • Shawn “JAY-Z” Carter, Chief Visionary Officer of The Parent Company, Leads Brand Strategy and The Parent Company Social Equity Ventures, a Corporate Venture Fund Investing in Black and Minority-owned Cannabis Businesses
  • The Parent Company is the Most Well-Capitalized Cannabis Company in the U.S. and is Positioned to Consolidate and Reshape the Market in California and Beyond
  • Investors Include Entertainment Powerhouse Roc Nation and Artists Rihanna, Meek Mill, Yo Gotti, and DJ Khaled
  • Common Shares are now Trading on the NEO Exchange Under the Symbol “GRAM.U” and OTCQX Under the Symbol “SBVCF”; Starting January 19, 2021 the OTCQX Symbol Will Change to “GRAMF”

SAN JOSE, Calif. and NEW YORK, Jan. 15, 2021 /PRNewswire/ — TPCO Holding Corp. (“The Parent Company”) (NEO Exchange: GRAM.U, GRAM.WT.U,OTCQX: SBVCF, SBVQF), formerly known as Subversive Capital Acquisition Corp. (“SCAC”) (NEO: SVC.A.U, SVC.WT.U;OTCQX: SBVCF, SBVQF), today announced the completion of its qualifying transaction (the “Transaction”) to acquire CMG Partners Inc. (“Caliva”), and Left Coast Ventures, Inc. (“Left Coast Ventures” or “LCV”) with global icon, entrepreneur and MONOGRAM founder, Shawn “JAY-Z” Carter and entertainment powerhouse Roc Nation.

Common Shares and Warrants are now trading on the NEO Exchange under the symbols “GRAM.U” and “GRAM.WT.U”, respectively, and remain trading on the OTCQX under the symbols “SBVCF” and “SBVQF,” respectively. Beginning January 19, 2021, the OTCQX symbol “SBVCF” will change to “GRAMF.”

Shawn “JAY-Z” Carter, The Parent Company’s Chief Visionary Officer, said, “This is an incredible time for this industry. The end of cannabis prohibition is here, and The Parent Company will lead the charge to a more expansive and inclusive cannabis industry. We are paving a path forward for a legacy rooted in dignity, justice, care, and consistency. The brands we build will redefine growth, social impact, and social equity. This is our time. I’m proud and excited to lead the vision of The Parent Company.”

Michael Auerbach, Chairman of SCAC and The Parent Company, added, “This is an industry defining moment. With its experienced management team, advanced infrastructure, industry leading operational efficiencies, proven strategy of brands, and cultural influence, The Parent Company will help shape the future of cannabis in the U.S. and beyond as well as begin to repair and rectify the wrongs of prohibition.”

Steve Allan, The Parent Company’s CEO, said, “With both the most comprehensive vertically integrated platform and brand portfolio in California, and the healthiest balance sheet in cannabis, we will reshape the industry in the world’s largest cannabis economy.”

For transaction details, investors and security holders may obtain a copy of the final prospectus (the “Prospectus”) associated with the Transaction on SEDAR at www.sedar.com and SCAC’s website at www.subversivecapital.com/s/Prospectus.

Effective on closing, the senior management team and board of directors were reconstituted as follows:

  • Steve Allan as Chief Executive Officer
  • Brett Cummings as Chief Financial Officer and President of Left Coast Ventures
  • Dennis O’Malley as Chief Operating Officer and President of Caliva
  • Shawn “JAY-Z” Carter as Chief Visionary Officer
  • Desiree Perez as Chief Social Equity Officer
  • Drew Kornreich as Chief M&A Officer
  • Colin Brown as Chief Legal Officer
  • John Figueiredo as President of SISU

Board of Directors:

  • Carol Bartz, former CEO of Yahoo! and Autodesk
  • Al Foreman, Partner of Tuatara Capital
  • Daniel Neukomm, CEO of La Jolla Group
  • Jeffry Allen, Director of Barracuda and former Director of NetApp
  • Leland Hensch, CEO of SCAC
  • Michael Auerbach, Founder and Chairman of SCAC

The Parent Company Investment Highlights

  • Proven Business Model – The Parent Company (TPCO) is a fully vertically integrated platform with cultivation, manufacturing, distribution, brands, retail and delivery to support further brand development and an aggressive M&A strategy. TPCO expects pro forma revenues of $334 million in 2021.
  • Progressive Operational Platform – TPCO owns its supply chain, enabling the company to leverage scale and profitably produce and distribute a broad portfolio of cannabis products for every consumer segment. The vertically integrated, omnichannel strategy maximizes gross profit and EBITDA margins, scales consumer reach, generates proprietary consumer data, and beats the illicit market on price, quality, and convenience.
  • Omnichannel Platform – TPCO’s scalable omnichannel business offers customers convenient express or scheduled delivery, and in-store or curbside pick-up, all through a single user-centric e-commerce platform, Caliva.com. This omnichannel e-commerce platform, offering both a robust portfolio of high-margin owned brands as well as third-party brands, allows The Parent Company to rapidly scale its direct-to-consumer reach to all Californians. Coupled with its powerful sourcing and low-cost manufacturing capabilities, this omnichannel platform offers consumers across California compelling pricing and convenience while remaining profitable.
  • Exclusive Brand Partnerships and Leading Cultural Influence – Brand strategy and marketing playbook led by Shawn “JAY-Z” Carter and Roc Nation, leveraging unparalleled cultural influence of leading artists and entertainers to build the most valuable and scalable brand portfolio in cannabis. JAY-Z officially launched the first his flagship cannabis line, MONOGRAM, on December 10, 2020.
  • Unrivaled Consumer Reach  TPCO currently reaches over 50% of consumers in California through Caliva.com, its existing direct-to-consumer platform. The Parent Company will have the greatest consumer reach of any cannabis company in California, reaching 75% of consumers in the state by the end of 2021 and almost 90% by the end of 2022 through scaling of its omnichannel platform.
  • Strong Balance Sheet –The Parent Company is the most well-capitalized cannabis company in the United States and will pursue an aggressive M&A strategy to accelerate growth, market share gains, and profitability.
  • Industry-Defining Social Impact  Led by Shawn “JAY-Z” Carter, The Parent Company will fund The Parent Company Social Equity Ventures with an initial target of $10 million and an annual contribution of at least 2% of its net income to invest in minority-owned and Black-owned cannabis businesses and contribute to the effort to rectify the wrongs of prohibition through diversifying both the business leadership and workforce of the cannabis industry. Beyond investing, the fund will also support organizations and programs focused on diversifying the cannabis workforce through job fairs and placement, industry training and education, as well as Social Equity application support.

Advisors
Canaccord Genuity Corp. served as financial advisor to SCAC. Blake, Cassels & Graydon LLP and Paul Hastings LLP acted as legal counsel to SCAC. Benesch Friedlander Coplan & Aronoff LLP served as U.S. legal advisor and lead transaction counsel, Boies Schiller Flexner LLP as U.S. transaction counsel, and Bennett Jones LLP as Canadian counsel to Caliva. Cooley LLP and Cassels Brock & Blackwell LLP acted as legal counsel to Left Coast Ventures. Cummings & Lockwood LLC, Reed Smith LLP, and Aird & Berlis LLP acted as legal counsel to Shawn “JAY-Z” Carter and his affiliate entities. Stikeman Elliot LLP acted as legal counsel to Canaccord Genuity Corp.

About The Parent Company          
The Parent Company (TPCO Holding Corp.) (NEO: GRAM.U, GRAM.WT.U,OTCQX: SBVCF, SBVQF) is California’s leading vertically integrated cannabis company combining best-in-class operations with leading voices in popular culture and social impact. The Parent Company brings together global icon and entrepreneur Shawn “JAY-Z” Carter, entertainment powerhouse ROC NATION, California’s leading direct-to-consumer platform CALIVA, and leading cannabis and hemp manufacturer, LEFT COAST VENTURES, to form a cannabis industry leader for the post-prohibition era. Chief Visionary Officer Shawn “JAY-Z” Carter, one of the most recognized and celebrated entrepreneurs of our time, will guide The Parent Company’s brand strategy in partnership with Roc Nation, the world’s preeminent entertainment company with a roster of culture-making artists, athletes and influencers. The brands we build together will pave a new path forward for a legacy rooted in equity, access, and justice.

About Roc Nation

Roc Nation, founded in 2008 by JAY-Z, has grown into the world’s preeminent entertainment company. Roc Nation works in every aspect of modern entertainment, with recording artists, producers, songwriters, and more. Roc Nation’s client list includes some of the world’s most recognizable names in entertainment, from Rihanna and Rapsody to Buju Banton and Snoh Aalegra. Roc Nation is a full-service organization, supporting a diverse roster of talent via artist management, music publishing, touring, production, strategic brand development, and beyond. Roc Nation Sports was founded in 2013, bringing the organization’s full-service touch to athletes across the NFL, NBA, MLB, and global soccer. For further information, visit rocnation.com.

Forward Looking Statements

This press release may contain forward-looking information within the meaning of applicable securities legislation which reflects The Parent Company’s current expectations regarding future events. The words “will”, “expects”, “intends” and similar expressions are often intended to identify forward looking information, although not all forward-looking information contains these identifying words.

Specific forward-looking information contained in this press release includes, but is not limited to, statements concerning the ability of The Parent Company to execute on its growth strategy and the future state of cannabis regulation in the United States. Forward-looking information is based on a number of assumptions and is subject to a number of risks and uncertainties, many of which are beyond The Parent Company’s control, which could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking information. Such risks and uncertainties include, but are not limited to: inability to obtain requisite regulatory or shareholder approvals, changes in general economic, business and political conditions, changes in applicable laws, the U.S. and Canadian regulatory landscapes and enforcement related to cannabis, changes in public opinion and perception of the cannabis industry, reliance on the expertise and judgment of senior management, as well as the factors discussed under the heading “Risk Factors” in the Prospectus which is available on SEDAR at www.sedar.com. The Parent Company undertakes no obligation to update such forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Contacts:
The Parent Company
Media
press@theparent.co
Investor Relations
investor@theparent.co

Subversive Capital 
Media
Berrin Noorata, media@subversivecapital.com
Investor Relations
Investor@subversivecapital.com

Source: PR Newswire – Subversive Capital Acquisition Corp. Closes The Largest Cannabis SPAC In History

Source: https://spacfeed.com/subversive-capital-acquisition-corp-closes-the-largest-cannabis-spac-in-history?utm_source=rss&utm_medium=rss&utm_campaign=subversive-capital-acquisition-corp-closes-the-largest-cannabis-spac-in-history

Continue Reading

Biotechnology

PAOG Publishes 2021 Cannabis Biopharmaceutical Strategic Outlook

Avatar

Published

on

Sandusky, OH, January 14, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today published a management outlook for 2021 on the company’s strategy to develop and monetize the cannabis assets acquired last year.  The strategic outlook is included in its entirety below:

PAOG 2021 Cannabis Biopharmaceutical Strategic Outlook

PAOG is a longtime participant in the cannabis sector working on initiatives to introduce cannabis treatments as alternatives to traditional pharmaceuticals, particularly where existing pharmaceutical treatments have potentially severe secondary ramifications as is the case with opioid based treatments.

Last year, the company shifted its primary focus to the development biopharmaceutical treatments derived from cannabis.

On July 30, 2020, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC PINK: KALY) RespRx is a cannabis treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method – U.S. Patent No. 9,199,960 entitled “METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT.”

PAOG also acquired a of hemp cultivation business from Puration, Inc. (OTC PINK: PURA).  This operation comes with existing sales activity and PAOG expects to report its first revenue from the acquisition in conjunction with the inclusion of Q4 2020 results into the overall 2020 financial report.

Since the two acquisitions, PAOG has been working diligently to develop and execute upon a strategy to monetize the assets in a manner that acheives self-sustainable operations at the same time delivering optimal shareholder value.

Toward that end, PAOG has entered into three strategic partnerships.

PAOG recently announced an engagement with Veristat, Inc., a contract research organization headquartered in Southborough Massachusetts. PAOG has engaged Veristat to assist in advancing PAOG with its proprietary Cannabidiol (CBD) extract for the treatment of Chronic Obstructive Pulmonary Disorder (COPD) toward initiating an Investigational New Drug application (IND) with the Food and Drug Administration (FDA).

Veristat, a scientific-minded global clinical research organization (CRO), enables sponsors to solve the unique and complex challenges associated with accelerating therapies through clinical development to regulatory approval. With more than 26 years’ experience in clinical trial planning and execution, Veristat is equipped to support any development program.

Learn more about Veristat at www.veristat.com.

PAOG management anticipates a pharmaceutical development process to be a long-term endeavor.  Management is committed to pursuing complimentary initiatives that have the potential to deliver revenue and profit in a shorter time frame.

PAOG has also recently engaged with the Puerto Rico Consortium for Clinical Investigation to assist PAOG with developing its proprietary Cannabidiol (CBD) extract into a nutraceutical product to provide care for those experiencing issues associated with Chronic Obstructive Pulmonary Disorder (COPD).

The Puerto Rico Consortium for Clinical Investigation (PRCCI) is a not-for-profit network of top performing, high-quality research sites invested in increasing the speed and quality of clinical trials. PRCCI enhances clinical research speed and quality by driving performance and efficiencies in research sites, leveraging strategic partnerships and by establishing world-class capabilities.

PAOG is targeting revenue in 2021 resulting from its nutraceutical developments.

Learn more about PRCCI at www.prcci.org.

PAOG has also entered into a strategic partnership with PURA in conjunction with PURA’s overall initiative in Farmersville, Texas.  In Farmersville, PAOG plans to build a pharmaceutical grade hemp cultivation facility and hemp extract facility.  The PURA partnership includes the opportunity to work in conjunction with PURA’s partnership with Alkame Holdings, Inc. (OTC PINK: ALKM).  PAOG plans to work with PURA and ALKM’s co-packing operations in the delivery of its CBD nutraceutical care solutions for those experiencing issues associated with COPD.

In a closing note to the strategic outlook, PAOG management is pleased to announce it has made the necessary application to authorize the issuance of a dividend of one share of PAOG stock to every holder of one share of PURA stock in accordance with the terms of the acquisition of the hemp cultivation business from PURA last year. PAOG anticipates announced dividend dates soon.

Learn more about PAOG at www.paogroupinc.com.

Forward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.

CONTACT INFORMATION

Contact Us:
Jim DiPrima
888-272-6472
info@pao.group

Source: https://otcprwire.com/paog-publishes-2021-cannabis-biopharmaceutical-strategic-outlook/

Continue Reading

Cannabis

The Cannabis Craze is Back in Gear (NASDAQ: SNDL) (NASDAQ: GRWG) (OTC US: MEDH) (OTC US: CRLBF)

Avatar

Published

on

Five more states just moved toward greater legalization of pot in November. And a Biden big blue wave win has now been confirmed and will also possibly usher in a federal decriminalization shift that could spur further changes that benefit current players in the cannabis space.

With the bull market in gear, the cannabis space has been one of the most dramatic beneficiaries, as growth estimates ratchet higher and excitement builds.

In other words, pot stocks are hot and running on tailwinds from legislative momentum and stock market enthusiasm, especially for speculative high-growth plays.

With that in mind, we take a look here at a handful of stocks that we think could be some of the most compelling opportunities in the space, including: Sundial Growers Inc. (NASDAQ: SNDL), GrowGeneration Corp (NASDAQ: GRWG), MedX Holdings Inc. (OTC US: MEDH), and Cresco Labs Inc. (OTC US: CRLBF).

Sundial Growers Inc. (NASDAQ: SNDL) trumpets itself as a licensed producer that crafts cannabis using state-of-the-art indoor facilities. The company cites its ‘craft-at-scale’ modular growing approach, award-winning genetics, and experienced master growers as the factors that set it apart from the competition in the rapidly growing cannabis space.

Sundial’s brand portfolio includes Top Leaf, Sundial Cannabis, Palmetto and Grasslands. Our consumer-packaged goods experience enables us to not just grow quality cannabis, but also to create exceptional consumer and customer experiences.

Sundial Growers Inc. (NASDAQ: SNDL) most recently announced that it has launched high-quality cannabis derivative products under the Top Leaf brand in response to rising consumer demands for solventless cannabis extracts. This most recent launch is consistent with Sundial’s focus on premium inhalables, following branded retail offerings of flower, pre-roll and vape cartridges.

“We made a strategic decision to produce these premium products based on demand for solventless, flavorful, pure, and potent cannabis concentrates from a growing group of consumers,” said Andrew Stordeur, President and Chief Operating Officer of Sundial. “Our control of the entire manufacturing process from cultivation to extraction enables us to deliver premium quality products on a consistent basis. Adding bubble hash and other advanced concentrates to our product portfolio will expand Sundial’s share of this rapidly expanding market segment.”

And the stock has been acting well over recent days, up something like 24% in that time. Shares of the stock have powered higher over the past month, rallying roughly 32% in that time on strong overall action.

Sundial Growers Inc. (NASDAQ: SNDL) generated sales of $9.7M, according to information released in the company’s most recent quarterly financial report. That adds up to a sequential quarter-over-quarter growth rate of -33.8% on the top line. In addition, the company is battling some balance sheet hurdles, with cash levels struggling to keep up with current liabilities ($19.7M against $76.6M, respectively).

GrowGeneration Corp (NASDAQ: GRWG) owns and operates retail hydroponic and organic gardening stores in the United States. If you’re looking for a red-hot name in the cannabis complex, GRWG is tough to beat.

The company carries and sells thousands of products, including organic nutrients and soils, advanced lighting technology and state of the art hydroponic equipment to be used indoors and outdoors by commercial and home growers.

GrowGeneration Corp (NASDAQ: GRWG) just yesterday reported preliminary record full-year 2020 revenue of $192 million, versus $80 million for 2019, an increase of 140%. As the Company continues to outpace guidance, it is increasing its 2021 revenue guidance range to $335 million-$350 million.

“We delivered strong shareholder value in 2020, with triple-digit revenue growth despite unprecedented challenges and an uncertain environment. This growth came through strategic acquisitions of best-in-class hydroponic stores, exceptional same-store sales growth, and the expansion of our omnichannel and private label offerings – a strategy we will accelerate this year,” said GrowGen CEO Darren Lampert. “We expect significant revenue growth in the year ahead as we continue to execute on these initiatives. Accordingly, we have raised our 2021 revenue guidance to $335-$350 million, our 2021 adjusted EBITDA guidance to $38 million – $40 million, and increased the number of projected GrowGen store locations to 55.”

GRWG shares have been acting well over recent days, up about 32% in that time.

GrowGeneration Corp (NASDAQ: GRWG) managed to rope in revenues totaling $55M in overall sales during the company’s most recently reported quarterly financial data — a figure that represents a rate of top line growth of 152.6%, as compared to year-ago data in comparable terms. In addition, the company has a strong balance sheet, with cash levels far exceeding current liabilities ($55.3M against $20.9M).

MedX Holdings Inc. (OTC US: MEDH) is a far more speculative opportunity, but could mature into a very interesting name in the cannabis and hemp space, particularly given its early-stage turnaround posture and the lack of speculative involvement in a market space that has become somewhat overburdened with speculative interest.

The company is focused on driving growth through vertical integration, strategic partnerships, licensing, franchising, and providing solutions to the emerging hemp and cannabis industry, and its recent reboot could provide an interesting bargain scenario before the crowd spots it.

MedX Holdings, Inc. (OTC US: MEDH) expects a final change of control of the majority shares to be transferred to Hans Enriquez within a couple weeks, which will complete the reboot in an official sense and lead to merging in new subsidiaries within the hemp and cannabis industries followed by a name and ticker change.

Stated CEO, Hans Enriquez: “I’m very pleased with the progress that has been made in the 6 months since I’ve come into MEDH and as the momentum of legalization continues to grow, we continue to position ourselves and look forward to a very prosperous year ahead.”

While this is a clear factor, it has been incorporated into a trading tape characterized by a pretty dominant offer, which hasn’t been the type of action MEDH shareholders really want to see. In total, over the past five days, shares of the stock have dropped by roughly -5% on above average trading volume. All in all, not a particularly friendly tape, but one that may ultimately present some new opportunities.

MedX Holdings Inc. (OTC US: MEDH) is effectively a new and promising member of the cannabis patch in the market. The company just regained OTC Markets access, got its last three periods of quarterly filings caught up, and achieved Pink Current status. That now sets up a refresh where MEDH is ready to begin executing its operational strategy for 2021. Given the dramatic strength in the group, that shift stands to potentially pay off for existing stakeholders.

Cresco Labs Inc. (OTC US: CRLBF) manufactures and sells medical cannabis products in the United States. It offers cannabis dry flower; vaporizer forms of cannabis; cannabis oil in capsule, oral and sublingual solutions; cannabis in topical; and other cannabis products.

The company also provides cannabis infused edibles, including chocolate and toffee confections, fruit-forward gummies, and hard sweet and chews. Cresco Labs Inc. sells its products under the Cresco brand. In addition, it operates a Hope Heal Health dispensary in Fall River, Bristol County, Massachusetts.

Cresco Labs Inc. (OTC US: CRLBF) recently announced the first annual report for its SEED (Social Equity and Educational Development) initiative. The report highlights the Company’s many achievements over the past year to help create a more diverse and inclusive cannabis industry through SEED’s restorative justice initiatives, community business incubators and educational and workforce development programming. The 2019-2020 SEED Annual Report is available online at crescolabs.com/seed.

“We are proud to have launched the cannabis industry’s first comprehensive social justice and social equity initiative and to report the significant strides the SEED program has made towards the more equitable inclusion of Black and Brown people in cannabis,” said Charlie Bachtell, CEO and Co-founder of Cresco Labs.

The context for this announcement is a bit of a bid, with shares acting well over the past five days, up about 14% in that timeframe. Shares of the stock have powered higher over the past month, rallying roughly 21% in that time on strong overall action.

Cresco Labs Inc. (OTC US: CRLBF) generated sales of $204.3M, according to information released in the company’s most recent quarterly financial report. That adds up to a sequential quarter-over-quarter growth rate of 56.4% on the top line. In addition, the company is battling some balance sheet hurdles, with cash levels struggling to keep up with current liabilities ($79.6M against $325.6M, respectively).

DISCLAIMER:  EDM Media LLC (EDM), is a third-party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  EDM is NOT affiliated in any manner with any company mentioned herein.  EDM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  EDM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  EDM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed EDM has been compensated four thousand dollars for news coverage of the current press releases issued by MedX Holdings Inc by the third party.

EDM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and EDM undertakes no obligation to update such  statements.

Media Contact:

EDM Media LLC

Email: IR@EDM.Media

Office: 800-301-7883

EDM.Media

Source: https://otcprwire.com/the-cannabis-craze-is-back-in-gear-nasdaq-sndl-nasdaq-grwg-otc-us-medh-otc-us-crlbf/

Continue Reading
NEWATLAS2 days ago

Lockheed Martin and Boeing debut Defiant X advanced assault helicopter

Blockchain5 days ago

Buying the Bitcoin Dip: MicroStrategy Scoops $10M Worth of BTC Following $7K Daily Crash

Blockchain5 days ago

Bitcoin Correction Intact While Altcoins Skyrocket: The Crypto Weekly Recap

Blockchain5 days ago

Canadian VR Company Sells $4.2M of Bitcoin Following the Double-Spending FUD

Blockchain5 days ago

MicroStrategy CEO claims to have “thousands” of executives interested in Bitcoin

Amb Crypto3 days ago

Former Goldman Sachs exec: Bitcoin ‘could work,’ but will attract more regulation

Amb Crypto5 days ago

Monero, OMG Network, DigiByte Price Analysis: 23 January

Amb Crypto5 days ago

Chainlink Price Analysis: 23 January

Amb Crypto4 days ago

Will range-bound Bitcoin fuel an altcoin rally?

Amb Crypto3 days ago

Other than Bitcoin, Coinbase notes institutional demand for Ethereum as well

Amb Crypto4 days ago

Bitcoin Price Analysis: 24 January

Amb Crypto5 days ago

Bitcoin Cash, Synthetix, Dash Price Analysis: 23 January

Amb Crypto5 days ago

Why has Bitcoin’s brief recovery not been enough

Automotive5 days ago

Tesla Powerwalls selected for first 100% solar and battery neighborhood in Australia

Amb Crypto3 days ago

Chainlink, Monero, Ethereum Classic Price Analysis: 25 January

Amb Crypto5 days ago

Stellar Lumens, Cosmos, Zcash Price Analysis: 23 January

AI4 days ago

Plato had Big Data and AI firmly on his radar

Amb Crypto5 days ago

Why now is the best time to buy Bitcoin, Ethereum

Amb Crypto2 days ago

Bitcoin SV, Ontology, Zcash Price Analysis: 26 January

Blockchain3 days ago

PayPal allows Bitcoin and cryptocurrency transactions

Trending